# 241 - ICH Q14 Explained: Have We Been Validating Methods Backwards?

Page: https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/241-ich-q14-explained-have-we-been-validating-methods-backwards
Text version: https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/241-ich-q14-explained-have-we-been-validating-methods-backwards.md
Podcast: [Let's Combinate - Drugs + Devices](https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248)
Published: 2026-06-10T10:00:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/letscombinate/episodes/241---ICH-Q14-Explained-Have-We-Been-Validating-Methods-Backwards-e3kj7lg
Audio file: https://anchor.fm/s/6770b9a0/podcast/play/121265264/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-5-10%2F425856065-44100-2-a30aa9e5ebe67.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/let-s-combinate-drugs-devices-4474248/episodes/241-ich-q14-explained-have-we-been-validating-methods-backwards
Duration seconds: 629

## Resource

In this final episode of the ICH Quality series, we walk through the most important concepts in ICH Q14 and how they fit into the broader ICH quality framework. Rather than reviewing the guideline section by section, this episode focuses on the ideas that are most useful in practice: Why does ICH Q14 start with the Analytical Target Profile (ATP)? How is it different from ICH Q2? How do you develop analytical procedures using a science- and risk-based approach? And what does all of this have to do with ICH Q12 and lifecycle management? One quick note: at the time of recording, ICH Q14 remains under public comment, so some details may evolve before the final version is adopted. Chapters 00:00 – Intro and ICH Q14 vs. Q2 01:08 – The Analytical Target Profile (ATP) 04:16 – The Analytical Procedure Lifecycle 05:32 – Risk-Based Development and Enhanced Approaches 06:20 – Where ICH Q2 Fits: Validation 08:04 – Connecting Q14 to ICH Q12 and Lifecycle Management 09:22 – Closing the ICH Quality Series In this episode, we cover: • Why ICH Q14 exists • The difference between ICH Q14 and ICH Q2 • What an Analytical Target Profile (ATP) is • ATP examples and performance criteria • Technology selection and fit-for-purpose methods • The analytical procedure lifecycle • Risk assessments and enhanced development approaches • Multivariate experiments and DOE concepts • Analytical procedure control strategies • Validation and the role of ICH Q2 • Lifecycle management of analytical procedures • The connection between ICH Q14 and ICH Q12 • Why understanding matters more than simply checking a box If you've followed along through the ICH Quality series, one of the themes that keeps showing up is that quality isn't something you test into products at the end. Whether we're talking about Q8, Q9…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/let-s-combinate-drugs-devices-4474248/episodes/241-ich-q14-explained-have-we-been-validating-methods-backwards/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/241-ich-q14-explained-have-we-been-validating-methods-backwards.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.